Susan Halabi

1992–2025 年に発表

154
論文数
28,114
被引用数
81
h 指数
147
i10 指数

被引用数

Susan Halabi の年別被引用数1943 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 8 件1996 年: 被引用 12 件1997 年: 被引用 8 件1998 年: 被引用 6 件1999 年: 被引用 17 件2000 年: 被引用 21 件2001 年: 被引用 43 件2002 年: 被引用 54 件2003 年: 被引用 67 件2004 年: 被引用 97 件2005 年: 被引用 122 件2006 年: 被引用 104 件2007 年: 被引用 113 件2008 年: 被引用 139 件2009 年: 被引用 189 件2010 年: 被引用 222 件2011 年: 被引用 237 件2012 年: 被引用 186 件2013 年: 被引用 208 件2014 年: 被引用 181 件2015 年: 被引用 159 件2016 年: 被引用 195 件2017 年: 被引用 189 件2018 年: 被引用 202 件2019 年: 被引用 707 件2020 年: 被引用 862 件2021 年: 被引用 924 件2022 年: 被引用 697 件2023 年: 被引用 562 件2024 年: 被引用 925 件2025 年: 被引用 473 件2026 年: 被引用 25 件1944〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,272 件、この内訳の 27%イギリス: 引用元論文 919 件、この内訳の 7.6%イタリア: 引用元論文 712 件、この内訳の 5.9%カナダ: 引用元論文 664 件、この内訳の 5.5%中国: 引用元論文 661 件、この内訳の 5.4%ドイツ: 引用元論文 632 件、この内訳の 5.2%フランス: 引用元論文 577 件、この内訳の 4.8%スペイン: 引用元論文 415 件、この内訳の 3.4%オーストラリア: 引用元論文 404 件、この内訳の 3.3%日本: 引用元論文 366 件、この内訳の 3%オランダ: 引用元論文 341 件、この内訳の 2.8%ベルギー: 引用元論文 314 件、この内訳の 2.6%
0%27%その他 23.5%

分野

  • Medicine80.2%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Immunology and Microbiology2.3%
  • Computer Science0.8%
  • Mathematics0.5%
  • Nursing0.5%
  • その他2.6%

トピック

  • Prostate Cancer Treatment and Research14%
  • Prostate Cancer Diagnosis and Treatment8.5%
  • Radiopharmaceutical Chemistry and Applications4.1%
  • Cancer Genomics and Diagnostics3.1%
  • Renal cell carcinoma treatment3.1%
  • Cancer Immunotherapy and Biomarkers3%
  • その他64.2%

共著者

全論文

検索で開く
  1. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  2. The Lancet Commission on prostate cancer: planning for the surge in cases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie - The Lancet 2024 被引用: 643

  3. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  4. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 2,241

  5. Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 364

  6. Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 463

  7. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 434

  8. Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 被引用: 409

  9. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118

  10. Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 715

  11. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 424

  12. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cecilia Mitchell, Alan W.C. Tan, Howard Streicher, Elad Sharon, Helen Moon, Michael Woods, Susan Halabi, Gabriela Perez Burbano, Michael J. Morris, Jonathan E. Rosenberg - New England Journal of Medicine 2024 被引用: 145

  13. Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer WithERBB2Amplification orERBB2/3Mutations: Results From the TAPUR Study

    著者: , , , , , , , , , , - JCO Precision Oncology 2022 被引用: 61

  14. Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update

    著者: , , , , , , , , , , , , , , , - European Journal of Cancer 2018 被引用: 400

  15. Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 182

  16. Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas J. Povsic, Michael Morse, Kenneth W. Mahaffey, Susan Halabi, Darryl P. Leong, Laurence Klotz, Neil Fleshner, G. Kenneth Jansz, Jonathan Giddens, R. Blair Egerdie, Joseph L. Chin, Joseph Zadra, Richard Casey, Jean Simard, Tamim Niazi, André‐Guy Martin, Marek Babjuk, Jaroslav Hájek, Jiří Klečka, Jiří Kubeš, Jan Schraml, Jitka Jakesova, J Vaňásek, Bohuslav Melichar, Heikki Seikkula, M. Abdiche, Marc Colombel, P. Debourdeau, G. Robert, Arnauld Villers, Guillaume Ploussard, Benjamin Pradère, F. Bruyère, Jean‐Luc Descotes, Idir Ouzaïd, Alexander Winter, Herbert Hanitzsch, H. Sperling, Ralf Eckert, Peter Hammerer, E. Stagge, F. Seseke, Silvio Szymula, Aristotelis Bamias, A. Thanos, Konstantinos Hatzimouratidis, Charalambos Mamoulakis, Haralabos P. Kalofonos, Elżbieta Oszukowska, Katarzyna Madziarska, Jacek Fijuth, Mateusz Obarzanowski, B. Yа. Alekseev, Vagif Atduev, Dmitri Pushkar, Evgeniy Veliev, A. V. Zyryаnov, С Б Петров, Evgeny Kopyltsov, Vadim Kozlov, Ladislav Macko, J. Dúbravický, Richard Polak, Obaidullah Mir, Marek Vargovcak, I. Minčík, J. Kliment, Frederico Gonçalves, J Mikuláš, Roman Sokol ほか 55 名 - Circulation 2021 被引用: 143

  17. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin - European Urology 2017 被引用: 643

  18. Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luis Parra-Rodriguez, Tatyana Der, Kate Willsey, Jun Wen, A Silverstein, Sean M. O’Brien, Hussein R. Al‐Khalidi, Michael A. Maldonado, Richard Melsheimer, William Ferguson, Steven E. McNulty, Pearl Zakroysky, Susan Halabi, Daniel K. Benjamin, Sandra Butler, Jane C. Atkinson, Stacey J. Adam, Soju Chang, Lisa M. LaVange, Michael A. Proschan, Samuel A. Bozzette, William G. Powderly, ACTIV-1 IM Study Group Members, Mihir Patel, Arun J. Sanyal, Jason Green, Huimin Wu, Benjamin P. Linas, Philip Grant, Vivek Iyer, Otto O. Yang, Bindu Balani, Sam Parnia, Ryan K Dare, Caryn G. Morse, Estelle S. Harris, Glenn Wortmann, Nicholas S. Hill, Shama Patel, Julia Garcia‐Diaz, Suman Thapamager, Megan Devine, Christine M. Bojanowski, Barry Meisenberg, Gailen D. Marshall, Dima Dandachi, Arick P. Sabin, Anthony Breemo, Suman Sinha, Christopher H. Goss, Rebecca Reece, Arlette Aouad, Seth Glassman, Peter E. Morris, Bela Patel, Fatimah Bello, Juliana Cardozo Fernandes, Oscar Carbajal, L Ravera, Mozar Castro, Miguel Villegas-Chiroque, Fernando Riera, A. Casado Camacho, Claudio Stadnik, Jorge Gave, Rodrigo Biondi, Ronal Gamarra Velarde, José Cerbino Neto, J. Ditondo, Marcelo Losso ほか 258 名 - JAMA 2023 被引用: 67

  19. Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , - Journal of Clinical Oncology 2014 被引用: 475

  20. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip W. Kantoff, Raja B. Khauli, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Robert E. Reiter, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Eric J. Small, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Bertrand Tombal, Levent Türkeri, Inge M. van Oort, A. Zapatero, Aurelius Omlin - European Urology 2020 被引用: 395

  21. Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study

    著者: , , , , , , , , , , , , - JCO Precision Oncology 2018 被引用: 180

  22. Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 41

  23. Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.

    著者: , , , , , , , , , , - European Urology Oncology 2021 被引用: 96

  24. Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 52